Astrazeneca (AZN) Debt to Equity (2011 - 2025)
Astrazeneca (AZN) posted quarterly Debt to Equity of -$0.52 for Q1 2026, up 20.57% year-over-year from -$0.43 in Q1 2025, and down 16.34% on a QoQ basis from -$0.44 in Q4 2025.
Astrazeneca (AZN) Debt to Equity (2011 - 2025) Analysis & Trends
Astrazeneca (AZN) has reported Debt to Equity for 18 consecutive years, with -$0.52 the latest figure, recorded in Q1 2026.
- In Q1 2026, Debt to Equity rose 20.57% year-over-year to -$0.52; the TTM figure through Mar 2026 stood at -$0.52 (up 20.57% YoY), while the FY2025 annual figure was -$0.44, down 162.92% from the prior year.
- Debt to Equity came in at -$0.52 for Q1 2026 at Astrazeneca, down from -$0.44 in the prior quarter.
- The five-year high for Debt to Equity was $0.76 in Q4 2022, with the low at -$0.77 in Q1 2022.
- Average Debt to Equity over 5 years is -$0.4, with a median of -$0.65 recorded in 2025.
- Across the five-year window, Debt to Equity soared 52.12% in 2022 and sank 162.92% in 2025, its largest moves.
- Year by year, Debt to Equity stood at $0.76 in 2022, then fell by 8.01% to $0.7 in 2023, then grew by 0.53% to $0.71 in 2024, then tumbled by 162.92% to -$0.44 in 2025, then dropped by 16.34% to -$0.52 in 2026.
- According to Business Quant data, Debt to Equity over the past three periods registered -$0.52, -$0.44, and -$0.54 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.39 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.68 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -9.70 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 1.07 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 6.24 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.94 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.72 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.44 |
| Dec 31, 2024 | 0.71 |
| Jun 30, 2024 | -0.69 |
| Dec 31, 2023 | 0.70 |
| Jun 30, 2023 | -0.65 |
| Dec 31, 2022 | 0.76 |
| Jun 30, 2022 | -0.74 |
| Dec 31, 2021 | 0.76 |
| Jun 30, 2021 | -1.54 |
| Dec 31, 2020 | -0.86 |
| Dec 31, 2019 | -0.82 |
| Dec 31, 2018 | -0.94 |
| Dec 31, 2017 | 0.74 |
| Dec 31, 2016 | -0.65 |
| Dec 31, 2015 | 0.57 |
| Dec 31, 2014 | 0.38 |
| Dec 31, 2013 | -0.45 |
| Dec 31, 2012 | -0.39 |
| Dec 31, 2011 | 0.31 |